Revelation Biosciences 8-K Filing
Ticker: REVBW · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1810560
| Field | Detail |
|---|---|
| Company | Revelation Biosciences, Inc. (REVBW) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, administrative
TL;DR
Revelation Biosciences filed an 8-K, updating corporate info and former name.
AI Summary
Revelation Biosciences, Inc. filed an 8-K on February 24, 2025, reporting an event on February 19, 2025. The filing indicates the company's former name was Petra Acquisition Inc., with a name change on April 23, 2020. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides official updates on Revelation Biosciences, Inc., including historical name changes and incorporation details, which are important for understanding the company's corporate structure and history.
Risk Assessment
Risk Level: low — The filing is primarily administrative and corporate information, not indicating significant operational or financial changes.
Key Players & Entities
- REVELATION BIOSCIENCES, INC. (company) — Registrant
- Petra Acquisition Inc. (company) — Former company name
- February 19, 2025 (date) — Earliest event reported
- February 24, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing for Revelation Biosciences, Inc.?
The primary purpose is to report current information as of February 19, 2025, including details about the company's incorporation and former name.
When was Revelation Biosciences, Inc. previously known as?
Revelation Biosciences, Inc. was previously known as Petra Acquisition Inc.
On what date did the company change its name from Petra Acquisition Inc.?
The company changed its name on April 23, 2020.
In which state is Revelation Biosciences, Inc. incorporated?
Revelation Biosciences, Inc. is incorporated in Delaware.
What is the fiscal year end for Revelation Biosciences, Inc.?
The fiscal year end for Revelation Biosciences, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding REVELATION BIOSCIENCES, INC. (REVBW).